CWM
LUMO

Concert Wealth Management’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Concert Wealth Management’s Portfolio LUMO Stock Details LUMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-1,680
Closed -$262K – 743
2016
Q1 		$262K Sell
1,680
-174
-9% -$35.3K 0.04% 500
2015
Q4 		$607K Buy
1,854
+241
+15% +$78.4K 0.08% 318
2015
Q3 		$529K Buy
+1,613
New +$709K 0.07% 347

Other funds holding LUMO

First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
TAM
Tiverton Asset Management Wilimington, Delaware $2.88B AUM 5.6% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BIM
Bogle Investment Management Newton Lower Falls, Massachusetts $63M AUM 51.97% 1-Year Est. Return

Concert Wealth Management's LUMO Position: Q2 2016 in Review

Concert Wealth Management sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q2 2016, closing a stake of 1,680 shares — an estimated $262K sold.

Concert Wealth Management first reported a position in LUMO in Q3 2015 and held it in 3 quarters. The position peaked at $607K in Q4 2015. 112 funds tracked by Wall St. Rank hold LUMO as of Q2 2016.

  • Concert Wealth Management reported no remaining Lumos Pharma, Inc. Common Stock position as of Q2 2016 after selling out during the quarter.
  • Concert Wealth Management sold 1,680 Lumos Pharma, Inc. Common Stock shares in Q2 2016, an estimated $262K.
  • Concert Wealth Management first reported a position in Lumos Pharma, Inc. Common Stock in Q3 2015 and held it in 3 quarters.
  • Concert Wealth Management's Lumos Pharma, Inc. Common Stock position peaked at $607K in Q4 2015.
  • 112 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q2 2016.

Based on Concert Wealth Management's 13F filing for Q2 2016, filed 28 Jul 2016.